Kaposi's sarcoma of the vulva: a case report and brief review.

Abstract	A report of a case of Kaposi's sarcoma of the vulva is presented. A complete response of the tumor was obtained after 1 treatment cycle using a triple-drug chemotherapy regimen of actinomycin D, vincristine, and 5-(3,3-dimethyl-1-trazeno)imidazole-4-carboxamide (DTIC). Death occurred due to severe erythema multiforme, which was indirectly related to a complication of the chemotherapy.
Authors	D J Hall, J C Burns, D R Goplerud
Journal	Obstetrics and gynecology (Obstet Gynecol) Vol. 54 Issue 4 Pg. 478-83 (Oct 1979) ISSN: 0029-7844 [Print] United States
PMID	492632 (Publication Type: Case Reports, Journal Article)
Chemical References	Antineoplastic Agents Dactinomycin Vincristine Dacarbazine
Topics	Antineoplastic Agents (administration & dosage) Dacarbazine (administration & dosage) Dactinomycin (administration & dosage) Drug Therapy, Combination Female Humans Middle Aged Sarcoma, Kaposi (drug therapy, pathology) Vincristine (administration & dosage) Vulvar Neoplasms (drug therapy, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!